PEspeaks

Jan 12, 2018
Pharmaceutical Executive
This post highlights the benefits of a new IT favorite for healthcare marketing, trigger emails.
Jan 12, 2018
Shared understanding of both risks and benefits to all parties in the healthcare continuum is essential in order to deliver more value, write Vickie Andros and Jake Caines.
Jan 10, 2018
If confirmed as the next secretary of the Department of Health and Human Services (HHS), Alex Azar says that a top priority is to make drugs more affordable.
Jan 09, 2018
Pharmaceutical Executive
The advent of immunocellular therapies marks a major milestone in medical innovation, but the path for these treatments in transforming patient care is still forming as they face challenges in clinical trials, pricing, and market acceptance.
Jan 08, 2018
Pharmaceutical Executive
Program puts a new—and very real—spin on patient nutrition.
Jan 07, 2018
Sponsored Content
This Q&A with Lumicell CEO Kelly Londy discusses new drug-device technologies in development for a range of cancers, beginning with breast cancer in the most advanced clinical studies.
Jan 03, 2018
William King offers five predictions on evolution of data and predictive insights that could be critical for pharma go-to-market strategies.
Dec 29, 2017
Pharmaceutical Executive
By Pharmaceutical Executive Editors
Senior Editor looks back over the past year at Pharm Exec and offers up her favorite articles.
Dec 21, 2017
Pharmaceutical Executive
While pricing issues need to be addressed in a transparent manner, what cannot be disputed is that the vast majority of the industry is committed to the discovery of vital new medicines with the power to change patients’ lives, writes Dr Steve Arlington.
Dec 20, 2017
Pharmaceutical Executive
In the search for effective and efficient ways to bridge the urban/rural divide, technological advances are offering more and more solutions.
native1_300x100
lorem ipsum